Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord mesenchymal stem cell transplantation for Parkinson's disease
ChiCTR-ONRC-12002937Phase 2Completed
- Sponsor
- The 105st Hospital of PLA
- Start
- Nov 2012
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of human umbilical cord mesenchymal stem cells in Parkinson's disease (PD) (2 arms), sponsored by The 105st Hospital of PLA. Primary endpoints: Unified Parkinson's Disease Rating Scale and Safety laboratory and clinical assessments. Started Nov 2012; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ChiCTR-ONRC-12002937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-12002937.